Ftse Mib
34.339,32
0,00%
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
62.876,69
-0,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Novelion Therapeutics Inc (NVLN) Novelion Therapeutics Inc (NVLN) Notizie

NVLN

Novelion Therapeutics (NVLN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NVLN
DataOraFonteTitoloSimboloCompagnia
30/03/202022:30Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:NVLNNovelion Therapeutics Inc
13/02/202022:52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
21/01/202023:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
15/01/202023:26Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLNNovelion Therapeutics Inc
17/12/201919:38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:NVLNNovelion Therapeutics Inc
12/12/201922:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLNNovelion Therapeutics Inc
15/11/201922:33Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:NVLNNovelion Therapeutics Inc
08/10/201914:10GlobeNewswire Inc.Novelion Therapeutics Announces Nasdaq DelistingNASDAQ:NVLNNovelion Therapeutics Inc
08/10/201914:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVLNNovelion Therapeutics Inc
04/10/201900:21GlobeNewswire Inc.Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matter...NASDAQ:NVLNNovelion Therapeutics Inc
03/10/201923:18Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVLNNovelion Therapeutics Inc
27/09/201923:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NVLNNovelion Therapeutics Inc
25/09/201914:25GlobeNewswire Inc.Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and OfficersNASDAQ:NVLNNovelion Therapeutics Inc
20/09/201923:23Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:NVLNNovelion Therapeutics Inc
11/09/201923:50GlobeNewswire Inc.Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Ann...NASDAQ:NVLNNovelion Therapeutics Inc
30/08/201914:02GlobeNewswire Inc.Novelion Therapeutics Provides Update Regarding Delisting from Nasdaq and Aegerion Bankruptcy CaseNASDAQ:NVLNNovelion Therapeutics Inc
23/08/201923:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVLNNovelion Therapeutics Inc
21/08/201923:09GlobeNewswire Inc.Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from NasdaqNASDAQ:NVLNNovelion Therapeutics Inc
12/08/201922:34GlobeNewswire Inc.Novelion Therapeutics Announces Anticipated Late Filing of Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2019NASDAQ:NVLNNovelion Therapeutics Inc
17/07/201900:43GlobeNewswire Inc.Novelion Therapeutics Announces Dismissal of Whitefort Capital PetitionNASDAQ:NVLNNovelion Therapeutics Inc
05/07/201914:30GlobeNewswire Inc.Novelion Therapeutics Receives Delisting NotificationsNASDAQ:NVLNNovelion Therapeutics Inc
24/06/201914:30GlobeNewswire Inc.Novelion Therapeutics Responds to Whitefort Capital PetitionNASDAQ:NVLNNovelion Therapeutics Inc
21/05/201904:53GlobeNewswire Inc.Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which...NASDAQ:NVLNNovelion Therapeutics Inc
07/05/201922:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVLNNovelion Therapeutics Inc
07/05/201922:01GlobeNewswire Inc.Novelion Therapeutics Reports First Quarter 2019 Financial ResultsNASDAQ:NVLNNovelion Therapeutics Inc
26/04/201915:01Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NVLNNovelion Therapeutics Inc
31/03/201908:00GlobeNewswire Inc.Novelion Therapeutics Observes World Lipodystrophy DayNASDAQ:NVLNNovelion Therapeutics Inc
29/03/201919:29Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NVLNNovelion Therapeutics Inc
15/03/201921:06Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVLNNovelion Therapeutics Inc
14/03/201922:12GlobeNewswire Inc.Novelion Therapeutics Reports Fourth Quarter and Full Year 2018 Financial ResultsNASDAQ:NVLNNovelion Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NVLN

La tua Cronologia

BIT
11COV
Covestro
BIT
18TRA
Traton
BIT
19MW
Marvell Technology
BIT
1A
Agilent Technologies
BIT
1AA
Alcoa
BIT
1AAD
Amadeus Fire
BIT
1AAG
Aumann
BIT
1AAL
American Airlines
BIT
1AAPL
Apple
BIT
1ABBV
Abbvie
BIT
1ABI
Anheuser Busch InBev SA NV
BIT
1ABNB
Airbnb
BIT
1ACA
Credit Agricole
BIT
1ACS
ACS Actividades de Const...
BIT
1AD
Koninklijke Ahold Delhai...
BIT
1ADBE
Adobe
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network